CORPORATE / BUSINESS

Cell Point IPO gets a ‘Subscribe for Medium to Long Term’ Rating from Analyst Nikhil Bhatt, key take-aways from his research report & GMP

Cell Point India, a leading smartphone & electronics retail company, is all set to make its debut in the stock market with its Initial Public Offering (IPO). The IPO presents a promising investment opportunity for those seeking long-term gains in the dynamic smartphone industry, says analyst Nikhil Bhatt in his Research report. With a strong track record of growth, strategic partnerships, and a wide range of products, Cell Point India is poised for success in the market.

The IPO, which opens on 15th June and closes on 20th June, will include a fresh issue of 5,034,000 shares at a fixed price of Rs. 100 per equity share. The total IPO size amounts to Rs. 50.34 crores. The listing is scheduled to take place on NSE’s Emerge platform on 29th June,2023. With First Overseas Capital Ltd. as the lead manager and Bigshares Services Pvt. Ltd. as the IPO registrar, Cell Point India is backed by experienced professionals in the financial industry.

As per the market observers, Cell Point IPO grey market premium (GMP) today is ₹14, which means grey market is expecting that Cell Point IPO listing price would be around ₹114 per equity share ( ₹100 + ₹14), which means the lucky allottees getting company shares on Cell Point IPO allotment date may expect around 14 per cent listing gain on Cell Point IPO listing date, which is most likely on 29th June 2023.

Cell Point India, founded by Mr. Mohan Prasad Panday and Mr. Bala Balaji Panday, started as a small mobile retail business in Visakhapatnam, Andhra Pradesh, and has grown into a network of over 75 retail stores across the state. The company’s primary focus is on retailing smartphones, tablets, mobile accessories, and related products from well-known brands. Through strategic partnerships with top smartphone manufacturers like Oppo, Vivo, Xiaomi, Realme, and more, Cell Point India enjoys exclusive rights and can offer quality products at competitive prices.

One of the key factors contributing to Cell Point India’s success is its omnichannel presence, providing customers with a seamless shopping experience across physical stores, online platforms, and mobile apps. This allows customers to browse, purchase, and receive support through their preferred channel, enhancing convenience and accessibility.

In addition, Cell Point India employs effective marketing strategies to reach a wider audience. This strong marketing presence enables Cell Point India to stay ahead of the competition. Another significant aspect of Cell Point India’s success lies in its commitment to exceptional customer service. With a trained and empowered staff, the company ensures responsive assistance and prompt resolution of customer inquiries and concerns. By providing personalised support and building trust and loyalty among customers, Cell Point India establishes itself as a reliable and customer-centric brand.

Cell Point India’s IPO proceeds will be utilised to repay borrowings, repair and renovate existing retail outlets, set up new stores, meet working capital requirements, cover general corporate expenses, and allocate funds for issue expenses. These strategic allocations aim to reduce debt, improve retail outlets, support operations, and ensure a successful IPO.

Considering the positive financial performance and growth potential of Cell Point India, coupled with its strong presence in the mobile retail industry, investors are encouraged to apply for long-term gains, says SEBI Registered analyst Nikhil Bhatt. The company’s remarkable progress over the past three years, with substantial growth in total assets, revenue, and profit after tax, showcases its ability to enhance profitability while expanding operations.

Furthermore, Cell Point India’s competitive edge through strategic partnerships, omnichannel presence, effective marketing strategies, exceptional customer service, and a wide range of products positions it for success in the ever-evolving smartphone market.

Mr. Bhatt concluded that the Cell Point India IPO presents an appealing investment opportunity for those seeking long-term gains. With a solid foundation, visionary leadership, and a commitment to customer satisfaction, Cell Point India is poised to capitalise on the growing demand for smartphones and related products. Invest wisely and secure your position in this dynamic industry.

Related posts

Dr. Kavita Gupta, Textile Commissioner, inaugurates HGH India 2018

Datar Cancer Genetics Announces break-through Innovative Ttreatment options for late-stage Cancer Patients

Record results in Grundfos strengthens foundation for the future

Leave a Comment

66 − = 58